Loading clinical trials...
Loading clinical trials...
Singleton pregnancies being diagnosed of fetal growth restriction from 24 to 32.6 weeks of gestation will be randomized to two equally sized groups: maternal oral supplementation with Lactoferrin and ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Institut d'Investigacions Biomèdiques August Pi i Sunyer
Collaborators
NCT05651347 · Fetal Growth Retardation, Stillbirth and Fetal Death, and more
NCT06952777 · Fetal Distress With Antenatal Problem, Fetal Growth Retardation
NCT05500989 · Pre-Eclampsia, HELLP Syndrome, and more
NCT04720690 · Arterial Stiffness, Fetal Growth Retardation, and more
NCT03398629 · Intrauterine Growth Restriction, Fetal Anomaly, and more
Hospital Clínic de Barcelona
Barcelona
Hospital de la Santa Creu i Sant Pau
Barcelona
Hospital del Mar
Barcelona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions